Skip to content
StockMarketAgent
Healthcare / Medical - Healthcare Information ServicesUpdated 2026-05-10 22:07 UTC

AIM/FDBK stock hub

AIM/FDBK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/FDBKis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.1M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/FDBK
In the news

Latest news · AIM/FDBK

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-90.5
P25 -54.2P50 2.1P75 13.7
ROIC-31.6
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/FDBK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
186
Groups with data
11
Currency
GBP
Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
29
Employees Change
2%
Employees Change Percent
7.41
Enterprise value
GBX 229,867
Exchange
London Stock Exchange AIM
Financial currency
GBP
First seen
2026-05-10
Industry
Medical - Healthcare Information Services
Isin
GB00BJN59X09
Last refreshed
2026-05-10
Market cap
GBX 4.1M
Price
GBX 9
Price currency
GBX
Rev Per Employee
29,297.34x
Sector
Healthcare
Sic
3845
Symbol
aim/FDBK
Website
https://feedbackmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-177.19%
EV Earnings
-0.03x
EV/FCF
-0.07x
EV/Sales
0.27x
FCF yield
-83%
P/B ratio
0.91x
P/S ratio
4.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
Gross margin
84.23%
Gross Profit
GBX 715,647
Gross Profit Growth
-8.09%
Gross Profit Growth Q
-15.75%
Gross Profit Growth3 Y
-13.41%
Gross Profit Growth5 Y
-5.32%
Net Income
GBX -7.2M
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-830.62%
Profit Per Employee
GBX -247,635
ROA
-29.38
Roa5y
-24.17
ROCE
-89.86
ROE
-90.47
Roe5y
-46.74
ROIC
-31.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr10y
-27.36%
Cagr15y
-21.27%
Cagr1y
-34.56%
Cagr20y
-21.7%
Cagr3y
-59.19%
Cagr5y
-48.77%
EPS Growth Quarters
1
EPS Growth Years
0
Revenue Growth
-28.82x
Revenue Growth Q
-8.02x
Revenue Growth Years
0x
Revenue Growth3 Y
-10.41x
Revenue Growth5 Y
-3.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
GBX 0.1
Assets
GBX 4.9M
Cash
GBX 3.8M
Current Assets
GBX 4.1M
Current Liabilities
GBX 400,000
Equity
GBX 4.5M
Liabilities
GBX 400,000
Long Term Assets
GBX 726,000
Long Term Liabilities
GBX 0
Net Cash
GBX 3.8M
Net Cash By Market Cap
GBX 94.33
Net Cash Growth
-47.33%
Net Debt Equity
GBX -0.86
Tangible Book Value
GBX 3.7M
Tangible Book Value Per Share
GBX 0.09
WACC
3.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
10.34
Net Working Capital
GBX -88,000
Quick ratio
10.34
Working Capital
GBX 3.7M
Working Capital Turnover
GBX 0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-224.22%
Dividend per share
GBX 0
Last Dividend
GBX 1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-95.91%
1Y total return
-34.55%
200-day SMA
11.28
3Y total return
-93.21%
50-day SMA
12.21
50-day SMA vs 200-day SMA
50over200
5Y total return
-96.47%
All Time High
34,800
All Time High Change
-99.97%
All Time High Date
2000-02-09
All Time Low
7.5
All Time Low Change
20%
All Time Low Date
2025-11-12
ATR
0.65
Beta
-0.09
Beta1y
0.94
Beta2y
-0.05
Ch YTD
-6.49
High
9.5
High52
15.3
High52 Date
2025-06-05
High52ch
-41.18%
Low
9
Low52
7.5
Low52 Date
2025-12-09
Low52ch
20%
Ma50ch
-26.3%
Price vs 200-day SMA
-20.23%
RSI
25.52
RSI Monthly
32.97
RSI Weekly
38.48
Sharpe ratio
-0.56x
Sortino ratio
-0.66
Total Return
-224.22%
Tr YTD
-6.49
Tr15y
-97.23%
Tr1m
-29.41%
Tr1w
-7.69%
Tr3m
-19.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
GBX -4M
Operating margin
-471.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
33,516,011%
Shares Insiders
4.41%
Shares Institutions
79.02%
Shares Out
43,814,779
Shares Qo Q
0.19%
Shares Yo Y
224.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
GBX -3.6M
Average Volume
199,534.15x
Bv Per Share
0.1
CAPEX
GBX -12,450
Ch10y
-95.91
Ch15y
-97.23
Ch1m
-29.41
Ch1w
-7.69
Ch1y
-34.55
Ch20y
-99.25
Ch3m
-19.28
Ch3y
-93.21
Ch5y
-96.47
Ch6m
5.26
Change
-2.7%
Change From Open
0
Close
9.25
Days Gap
-2.7
Depreciation Amortization
17,271
Dollar Volume
237,897
Earnings Date
2026-05-18
EBIT
GBX -4M
EBITDA
GBX -4M
EPS
GBX -0.16
F Score
1
FCF
GBX -3.4M
FCF EV Yield
-1,463.32x
FCF Per Share
GBX -0.08
Financing CF
496,487
Fiscal Year End
May
Founded
1,958
Income Tax
GBX 124,260
Investing CF
-581,998
Is Primary Listing
1
Last Earnings Date
2026-02-17
Last Report Date
2025-11-30
Last Split Date
2022-10-14
Last Split Type
Reverse
Ma150
10.69
Ma150ch
-15.82%
Ma20
10.64
Ma20ch
-15.41%
Net CF
-3,435,746
Next Earnings Date
2026-05-18
Open
9
Position In Range
0
Ppne
9,000
Price Date
2026-05-08
Ptbv Ratio
1.08
Relative Volume
0.13x
Revenue
849,623x
SBC By Revenue
24.83x
Share Based Comp
210,930
Tax By Revenue
14.63x
Tr20y
-99.25%
Tr6m
5.26%
Volume
26,433
Z Score
1.1
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/FDBK pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/FDBK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-34.5%
S&P 500 1Y: n/a
3Y total return
-93.2%
S&P 500 3Y: n/a
5Y total return
-96.5%
S&P 500 5Y: n/a
10Y total return
-95.9%
S&P 500 10Y: n/a
Ownership

Who owns AIM/FDBK?

Insider, institutional, and short-interest positioning.

Institutional ownership
+79.0%
Share of float held by funds and institutions
Insider ownership
+4.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+224.2%
Negative means the company is buying back shares.
Technical

AIM/FDBK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
25.5
Below 30: short-term oversold
Price vs 200-day MA
-20.2%
50/200-day relationship not available
Beta (5Y)
-0.09
Less volatile than the market
Sharpe ratio
-0.56
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/FDBK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/FDBK stock rating?

aim/FDBK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/FDBK analysis?

The full report lives at /stocks/aim/FDBK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/FDBK?

The latest report frames aim/FDBK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/FDBK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

aim/FDBK stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA